According to the company, information on best worming strategies for foals and yearlings remains largely anecdotal, making it difficult to develop a clear plan for this age group. Zoetis veterinary surgeon Wendy Talbot has therefore reviewed the recent literature to develop an eight-point plan.
Explaining the guidance, Wendy writes:
Foals and yearlings are usually more susceptible to worms than are adult horses because they have had little chance to develop any immunity. They are more vulnerable to related diseases and tend to have higher egg shedding, which increases the risk of infection. The main parasitic culprits in the UK for foals less than six months of age are large roundworms (ascarids). In older foals and weanlings, small and large strongyles, tapeworms (and pinworms) are the main considerations.1 Yearlings may also have a second wave of large roundworm infection at 8-10 months of age.2 Any control strategy will need to take into account the individual circumstances such as stocking density, pasture management and previous disease history.
Guidelines for parasite control in foals suggest a first treatment with fenbendazole at 2-3 months of age, targeting large roundworm, followed by another treatment at 5-6 months. Alternatively, pyrantel may be considered for these doses; however, there may be resistance in some areas and foals with large adult ascarid burdens may be at higher risk of intestinal rupture when this drug is used.4 At weaning (approximately six months of age), it is advisable to perform a faecal worm egg count (FWEC) to determine if treatment for strongyles is also required; the macrocyclic lactone anthelmintics (ivermectin or moxidectin) are expected to have the highest efficacy. At 9 and 12 months of age treatment for stronglyes and a larvicidal dose for encysted stages of small strongyles (moxidectin or a 5 day course of fenbendazole) are indicated. A tapeworm treatment should be included with one of these doses.2,3
For yearlings, two methods have recently been proposed for worm control: the first involves using faecal worm egg counts (FWECs) at more frequent intervals than for adults to guide dosing for strongyles in the grazing season.1 The second suggests three baseline treatments targeting strongyles in spring, summer and late autumn, with FWECs in between to identify and treat any still shedding high numbers of eggs, up to a maximum of six treatments per year.2 Macrocyclic lactones have the highest expected efficacy against small strongyles and should form the basis of treatments; however, pyrantel can be considered for some treatments where it has been shown to have continued efficacy. Both strategies include a larvcidal treatment for encysted small redworm combined with testing or treating for tapeworm in late autumn. The inclusion of one or two doses of a macrocyclic lactone each year (usually already used for small strongyle control) should be sufficient to prevent large strongyle related disease.3
The wide differences in the circumstances of foals and yearlings, together with geographical variations in resistance patterns and a lack of consensus on best practice in this group means it is not possible to define a single approach to a worming plan. An important point to note is that FWECs may give surprising results because higher counts are generally seen in youngstock.
Eight ways to keep clients' youngstock worms controlled:
For further information on worming together with some equine specific CPD visit: https://blog.vetsupportplus.com/
The day-long CPD course will everything from routine neutering and vaccination, to common presentations like gastrointestinal stasis, renal disease and osteoarthritis, through to more advanced surgical challenges, such as the management of auricular and dental abscesses, liver lobe torsion and small intestinal obstructions.
The day will be divided into lectures given by Marie and Richard, starting with the more common clinical scenarios before extending into the more challenging cases.
Delegates are also invited to prepare any tricky cases to discuss in an open session at the end of the day.
The course costs £300 per delegate, including tea, coffee and buffet lunch plus electronic course notes.
https://evolutionexoticsreferrals.co.uk/cpd-booking-form
Snowflake previously had a squamous cell carcinoma mass on the right lower eyelid, which was completely removed in 2018.
However, her owner noticed an abnormal growth in the left eye, and brought her back to the RVC.
On presentation, Snowflake was bright and in good body condition, weighing 71kg.
Both eyes were open and appeared comfortable and visual.
Ocular reflexes and responses were also present as expected and there was no evidence of recurrence of the squamous cell carcinoma on the lower right eyelid.
Snowflake was, however, diagnosed with mild cataracts in her right eye deemed unlikely to interfere with her vision.
In addition, the mass of her left third eyelid was nonpigmented and displayed a poorly defined mass-like lesion, with an irregular surface on the leading edge, appearing consistent with a squamous cell carcinoma.
The team, led by Dr Maria-Christine Fischer, Lecturer in Ophthalmology, Dr Sara Lawrence-Mills, Senior Clinical Training Fellow in Anaesthesia, and Dr Carolina Palacios Jimenez, Lecturer in Anaesthesia, decided to undertake surgery.
They removed the third eyelid under sedation and applied local anaesthetic blocks and topical tetracaine eye drops.
Cryotherapy was then applied to the wound edge as an adjunctive therapy.
The RVC says that to date, there are few publications detailing anaesthesia in reindeer and so this protocol was a novel approach to maintaining a safe level of sedation in a well-domesticated animal.
The College added that the use of these nerve blocks to facilitate ophthalmic surgery has not been reported before and is in the process of being published.
Snowflake’s third eyelid was submitted for histopathology, which confirmed the diagnosis of squamous cell carcinoma, which the team at the RVC was able to remove completely.
During the process, Snowflake’s daughter was with her so they both remained calm, and she has now made a full recovery and has enjoyed being reunited with her herd.
Maria-Christine said: “Snowflake had a cancerous mass on her third eye lid.
"Surgical removal of the third eyelid in a reindeer has not been reported before.
"We were pleased that we could perform the surgery with Snowflake under a standing sedation and with using local anaesthetics.
"As an ophthalmologist, I am committed to preserving vision so it’s rewarding that we were able to completely excise the tumour and did not have to remove the eyeball. It’s a very good outcome.
"I’m also pleased that Snowflake recovered quickly from the procedure, and we were able to share the protocol of the sedation and the local nerve blocks with other vets via a scientific publication.
"Sharing our knowledge will hopefully be beneficial for future ophthalmic surgeries in reindeer.”
* aka Mr Nick Dean.
Professor Sandy Trees has been invested as the new President of the Royal College of Veterinary Surgeons during RCVS Day, held on 3rd July.
Sandy is an Edinburgh graduate, qualifying from the Dick Vet in 1969. After graduation, he undertook a mixture of research posts at home and overseas, plus a spell in general practice, before completing his PhD in 1976, also at Edinburgh. He then spent some time in the animal health industry before moving into academia in the early 1980s, starting as a lecturer in veterinary parasitology in Liverpool University's Faculty of Veterinary Science, based in the Liverpool School of Tropical Medicine. He was awarded a personal chair in veterinary parasitology and became Head of the Parasite and Vector Biology Division in 1994. Sandy held the post of Dean of Faculty from 2001 until 2008, and still teaches BVSc, MSc and PhD students.
Sandy's broad veterinary political experience includes spells on the BVA's Veterinary Policy Group and Education Group, President of the Association of Veterinary Teachers and Research Workers, Vice-President of the European College of Veterinary Parasitology and Chairman of the Heads of Veterinary Schools. Serving on RCVS Council since 2000 as one of the Liverpool veterinary faculty's appointed members, Sandy has been a member of the Education Policy and Specialisation, Planning and Resources, and Preliminary Investigation Committees.
RCVS Day also brought other changes to the RCVS Officer team: Jill Nute, outgoing President, became Senior Vice-President, Peter Jinman took up the role of Junior Vice-President, and Dr Jerry Davies was confirmed as Treasurer for another year.
Dr Bob Moore stood down as Senior Vice-President, with Jill Nute commenting that: "Bob has been an extremely valued member of the Officer Team and I would like to express my grateful thanks for the unstinting support he has given me during my term as President."
Retiring Council members included David Harding, Nigel Swayne and Brian Jennings, a Privy Council appointee.
As part of the AGM, newly-elected Council members Chris Tufnell and Chris Gray were welcomed. It was also announced that Professor Stephen May had been appointed for a further year by the Royal Veterinary College, Professor Stuart Reid had been appointed for a further four-year term by the University of Glasgow, and likewise Caroline Freedman by the University of Edinburgh. Dr Frank Taylor, whose role as Head of Bristol Veterinary School is due to conclude at the end of the month, will stay on Council until a successor is appointed.
The President then made her outgoing address, in which she described how she had been keen during her presidential year to ensure that the College is "open, approachable, accountable and transparent," citing the work of the Corporate Governance Group as a good example of activities to this end: "Under the guidance of Sir Anthony Holland, Chairman of the Group, we have robust procedures in place for managing conflicts of interest and have put in place arrangements to keep corporate governance under regular review," she said.
Discussing the activities of the College during the year, she made mention of work with the Veterinary Medicines Directorate to produce the Register of Veterinary Practice Premises and with the Office of Fair Trading regarding monitoring the reintroduction of prescription charges. She also touched on the review of the Practice Standards Scheme and the work of the 24/7 Working Party. She conceded that the College faced a challenge with regards to out-of-hours cover, which the majority of vets questioned in a recent survey would like to maintain: "The question is, how can this be achieved within the law [Working Time Regulations] and without a hike in charges that might, perversely, have a negative effect on animal welfare by reducing take-up of veterinary services?" she asked.
Finally, Jill paid tribute to the hard work of College and Trust staff, Council members and her fellow Officers: "One thing you learn as President is that you are just part of the bigger picture and things can only be achieved with the support and collaboration of those across the profession."
Incoming President Sandy Trees described Jill Nute as having "presided over the College with utter fairness and even handedness, working incredibly hard for the interests of the College and its members, certainly delivering on your aim for openness and accessibility". He looked forward to his own presidency with "honour, excitement and trepidation".
Two new edition's of Veterinary Focus, Royal Canin's free journal for companion animal veterinary surgeons are now available free of charge to UK vets.
Focus on Respiratory Disease includes features on brachycephalic syndrome, feline asthma, thoracic radiography of respiratory cases, canine fungal rhinitis, tracheobronchial foreign bodies in dogs and cats, emergency care of patients with acute respiratory distress, and respiratory parasitic diseases. Contributors include representatives from veterinary universities in Germany, Spain, Italy, the USA, and Argentina, and from the UK, Martin Sullivan BVMS, PhD, DVR, Dipl. ECVDI, MRCVS from Glasgow University and Mike Stafford Johnson, MVB, MRCVS, DVC Cert, SAM, MACVS from the Veterinary Cardiorespiratory Centre in Kenilworth.
Focus on Liver Disease includes features on feline inflammatory liver disease, canine portosystemic shunts, jaundice in the dog, extra-hepatic biliary system surgery, laboratory tests for liver disease, liver enzyme testing, diagnosis and treatment of liver tumours, and liver biopsy sampling. Contributors include representatives from veterinary universities in France, Spain, Italy, the USA, New Caledonia, Argentina, and Grenada, and from the Faculty of Veterinary Medicine, University of Edinburgh, Danielle Gunn-Moore, BSc. BVM&S, PhD, FHEA, MACVSc, MRCVS, Nicki Reed, BM&S, Cert VR.DSAM (Feline) Dipl. ECVIM-CA, MRCVS, and Kathryn Pratschke, MVB. MVM, Cert SAS, Dipl. ECVS, MRCVS.
Lee Danks, Royal Canin Veterinary Support manager, said: "Focus is a really interesting and informative publication, and with each issue focusing on a particular body system it offers a complete review of the latest thinking in each area. The contributors are all highly renowned in their individual fields, and being able to provide this kind of expertise to our veterinary partners is something we are really proud of."
Veterinary Focus is published in English, French, German, Chinese, Italian, Polish, Portuguese, Spanish, Japanese, Greek and Russian and reaches over 80,000 veterinary surgeons worldwide.
For a free copy of Focus, speak to your Royal Canin veterinary business manager, who will add you to the subscription list.
Merial Animal Health has announced that the duration of immunity for the tetanus component of Proteqflu-Te has been extended to 2 years.
Merial's Veterinary Technical Manager Kevin Whelan said: "This is a welcome new addition to the label claims for this advanced vaccine, which is the only equine flu vaccine in the UK to contain a recently updated influenza virus strain. The updated strain, innovative canarypox vector technology and now the extended tetanus duration of immunity claim make the vaccine an excellent choice for vets in the UK"
Merial says Proteqflu-Te can now be used on an alternate year basis in combination with the company's other flu vaccine, Proteqflu, which does not contain tetanus toxoid. The one year duration of immunity for the influenza component remains unchanged.
Please contact your local Merial Representative or the Merial Technical Support line on 0870 6000 123 for further information.
The National Office of Animal Health has issued a statement criticising the All Party Parliamentary Group on Antibiotics report: "Non-human uses of antibiotics: time to restrict their use?”, saying it fails to recognise the steps that have already been taken by vets and farmers to prevent disease and minimise antibiotic use on farms where possible.
NOAH chief executive Dawn Howard said: "NOAH fully supports the need for responsible prescribing, by both the veterinary and medical professions.
"On the veterinary side, NOAH has been very actively involved with responsible use initiatives, such as the RUMA Alliance, which publishes guidelines supporting responsible use and has produced an action plan on livestock antibiotic resistance to implement Government strategy.“
NOAH highlights two particular aspects of the report. Firstly that it is critical of the treatment of groups of animals through medicated feed and water.
Dawn said: "There are many animal-friendly reasons why medicines can be prescribed in this way by a veterinary surgeon.
"For groups of animals, fish or birds there is less stress than injection or individual oral dosing. Where treatment is needed, the vet supplies a prescription for treatment through medicated feed or through the water, depending on the product being used. The whole process is highly regulated through European and national legislation."
The report also suggests certain classes of antibiotics should be reserved for humans. NOAH says it believes that veterinary surgeons need to retain the full range of currently licensed antibiotics in order to be able to treat the range of conditions that affect animals, and if they are restricted, animal welfare will undoubtedly suffer.
NOAH adds that removal of some classes from the veterinary sector would place undue selective pressure on the remaining classes which could increase resistance to those classes – having the opposite effect to what the committee probably intends.
Dawn said: “NOAH is disappointed not to have been consulted in advance of the publication of the report. We believe that responsible use of veterinary antibiotics is the best way to help preserve these precious medicines for us all, without compromising the health and welfare of our animals.”
Running from 14th-23rd July, the interactive webinars will be delivered in 5 half-day sessions, led by UK pet food consultants, scientists, and vets.
The course includes:
Sarah Hormozi, PFMA Head of Science & Education, said: "With some of the most credible industry experts as our speakers, this is a rare opportunity for pet professionals across the UK and EU to improve and refresh their knowledge of animal nutrition, pet food legislation, marketing regulations and manufacturing methods, from the comfort of their own home or office!”
For the full programme, list of speakers, registration details and prices, visit www.pfma.org.uk/pfma-training-webinar-series.
Participating practices will learn about dental disease pathophysiology and diagnosis, gain insights in pet owner behaviour and learn how to increase client engagement while implementing a dental home care plan.
Animalcare has also made available free social media packs and waiting room materials to help educate clients on pet dental health.
Will Peel, Marketing Manager at Animalcare said: ‘We know that UK veterinary surgeons consider dental disorders to be one of the most important health related welfare issues currently affecting UK dogs.
"We’ve introduced our CPD sessions to help the entire veterinary team learn more about dental disease and to help them educate their clients about implementing an at home dental regime which works for them and their pets.'
To book your Lunch and Learn or request a social media pack and other materials, contact your local Animalcare territory manager or email animalcare@animalcare.co.uk.
The Registry’s dataset now contains the details of 1,319 canine cruciate surgical procedures, compared with 735 reported in 2023.
The report contains 3 years of data provided by 138 UK-based vets and their clients, and reports on cruciate surgery outcomes on dogs from all stages of life – from 3 months to 18 years.
The report provides a breakdown of the clinical outcomes of different surgical techniques, patient demographics, use of antibiotics, and more.
Some of the main findings in this year’s annual report were:
Mark Morton, Clinical Lead for the Registry, said: “It has been fantastic to see the CCR go from strength to strength this year with contributions from owners and vets across the country.
"Evaluating what we do and sharing this information with owners is really important.
"There is now sufficient data in the registry that vets can use the reporting functionality to see how they compare to anonymous data from the registry as whole.
"This allows everyone to look at where we can improve what we do to enhance outcomes for our patients.”
Steve Butterworth, veterinary surgeon at Weighbridge Referral Service, Swansea, and CCR contributor, said: “To better understand the long-term outcomes for different breeds of dog using differing surgical techniques we need the power of numbers and this will only be achieved by pooling our resources.
"The CCR offers the veterinary profession an opportunity to do this.
Any veterinary surgeon performing cruciate surgery in the UK can get involved in the CCR by signing up and logging surgical cases.
All data submitted by summer 2025 will be anonymised and become part of the next report in late 2025.
ccr.rcvsknowledge.org/annualreport
CEVA Animal Health has extended its behavioural range of products with the launch of Senilife®, a nutritional supplement which is specifically formulated to help manage signs of brain ageing in dogs and cats.
Senilife® contains a combination of three essential brain nutrients - phosphatidylserine, vitamin B6 and vitamin E - which the company says help maintain membrane fluidity and normalise neurotransmission. In addition, two natural but potent anti-oxidants - gingko biloba and resveratrol - support brain metabolism and help to neutralise free radicals and reduce amyloid deposits.
According to CEVA, common signs of brain ageing in dogs and cats include playing or interacting less, barking or howling at night, loss of house-training/litter box training, apathy or increased tiredness and disorientation. A study has shown that up to 75% of dogs over seven years of age and 35% of cats 11 years and over suffer from at least one geriatric behavioural problem1.
In a recent clinical study, 86% of owners were satisfied with the results achieved after one month of using Senilife®, with 73% of dog owners and 67% of cat owners noticing fewer signs of brain ageing within the first seven days2.
Juliet Penaliggon, small animal marketing manager at CEVA Animal Health, says: "Many typical signs of brain ageing in dogs can be controlled by nutritional management. Senilife® is a fast-acting, nutritional supplement that contains proven nutrients and neuroprotectives to help manage these signs."Senilife® capsules are easy to administer either directly into the mouth of the pet or emptied onto the pet's food."
For further information, please contact your CEVA Animal Health representative or call 01494 781510.
References1 Behaviour problems in geriatric pets. Lansberg G and Araujo J. Vet Clin North Am Small Anim Pract. 35 (2005) 675-698.2 Isaka N, Baysse B, Lopez A, Ovaert P and Penaliggon J. CABSTG Spring Meeting April (2009).
BCF has announced upgrades to the Easi-Scan bovine ultrasound scanner which include improved image quality and additions to the BCF Universal Googles (BUGs) range.
The BUGs range now includes a new LCD model and a monocular version. According to the company, the LCD version provides a softer, more familiar image and considerably lower price, while the monocular version is ideal for the small percentage of people that struggle to see a single image in a binocular style goggle.
John Dawson from Willows Veterinary Group, Cheshire said: "The LCD BUG has a softer image which I prefer. They give more differentiation of echogenic grading allowing more detail to be seen. When I first used them I thought they were going to be more expensive, but to get a better image at a lower price I was astonished."
Gavin Mitchell from BCF said: "These new product developments for Easi-Scan and BUGs are a great illustration of how we are committed to responding to our customers' feedback, opinions and recommendations. At BCF, we design, develop and manufacture our own equipment. It is so important to continually work closely with our customers, to continue to create world-leading ultrasound equipment."
For more information visit www.bcftechnology.com
For the randomised controlled trial, 528 dairy heifers were monitored for 34 months to investigate the effects of routine treatment with a NSAID at calving and during treatment for lameness, on the future probability of lameness and culling.
The cows were exposed to normal farm conditions and were split into four groups:
During the study, the probability of lameness was assessed by a lameness outcome score collected every 14 days.
Data on culling was also extracted from farm records.
438 animals were included in the final analysis which revealed that treating a cohort of cows following the group three protocol led to an absolute reduction in lameness of approximately 10% and severe lameness of 3%, compared with animals treated in accordance with conventional best practice (group one).
James Wilson BSc(Hons) PhD, foot health consultant and lead researcher on the trial, said: “It appears that through giving heifers a NSAID at critical time points, we have imparted a substantial, long-lasting benefit to them.
"When freshly calved heifers enter the herd for the first time, we understand that they are (typically) naïve to lameness and have good hoof health.
"By utilising NSAIDs strategically, we believe that we have preserved the functionality of the foot, thereby reducing the risk of lameness.
"This is a highly efficacious, cost-effective means of managing lameness on farm.”
Herd Health Consultancy says that in dairy cows, it is advisable to consider using a zero milk-withhold NSAID which is fully licensed to treat lameness in cattle to avoid any need to discard milk, however no NSAID is currently licensed in the UK to treat the pain associated with calving, so careful advice should be given to farmers based on the farm type and production methods.
https://doi.org/10.3168/jds.2021-21329
Reference
Jonathan Hill, UK country manager at Dômes Pharma said: "Dômes Pharma is really excited to be extending our pet anxiety range to help vets manage cases in this complex area.
https://domespharma.co.uk/products/fluoxevet/
The Office of Fair Trading has concluded that it has no grounds to take action against IDEXX Laboratories Limited following an investigation into alleged abuses of a dominant position in the veterinary diagnostic testing sector.
The OFT opened its investigation in November 2010 after it received a complaint alleging that IDEXX was abusing a dominant position in the market for the supply of in-clinic pet testing equipment in order to foreclose competition.
The conduct assessed by the OFT included alleged practices of:
The full reasoning for the OFT's conclusion, including details of the methodologies used by the OFT to assess potential theories of harm relating to alleged mixed bundling (also known as multi-product rebates) and alleged predatory pricing in systems markets, is available from the OFT's website, here.
Sioned Timothy, Ruminant Technical Manager at Boehringer said: "The financial and production impact of liver fluke should not be underestimated. Recent abattoir research in Ireland, published this year, has shown that a fattening steer with fluke infection will put on 36kg less live weight gain over its lifetime versus a healthy steer, costing the producer around £63, per animal.
"Additionally, analysis of data from cattle at a Scottish abattoir showed that animals with 1 to 10 liver fluke present in their liver took an average 31 days longer to reach slaughter weight, while animals with more than 10 liver fluke present took an additional 77 days longer to reach slaughter weight versus animals without any liver fluke infection2.
"Liver fluke infections can also lead to hormonal and metabolic imbalances, affecting reproduction in female animals and extending breeding targets3. Affected animals may also be more susceptible to secondary bacterial infections, such as Salmonella and Clostridial infections3."
Boehringer says that with cattle being brought in for winter housing, now is an ideal opportunity to remove productivity-limiting parasites that were acquired during the grazing season. The main targets for parasite control at this time of year are gutworms, lungworm and liver fluke, however the specific risk will vary from farm to farm.
The company adds that the choice of treatment for liver fluke at housing is complicated by emerging resistance to triclabendazole. This is the only flukicide that treats the early immature stage of liver fluke, responsible for acute disease in sheep but not of clinical relevance in cattle.
Sioned said: "Prescribing an alternative flukicide for cattle at housing will reduce selection for resistance and, by targeting the later stages of the parasite, control the impact of liver fluke on productivity.
"Flukicides containing clorsulon (contained in Ivomec Super) will remove the adult stages of fluke in cattle, while those containing closantel, or nitroxynil (the active ingredient of Trodax), are effective against both late immature and adult stages.
"To ensure that cattle have no residual fluke burden, they may need to be re-treated at an appropriate interval after the initial housing dose. Diagnostic testing can be used to determine whether a second treatment is necessary. This approach will ensure that cattle are turned back out onto pasture fluke free."
References
The survey of 102 UK veterinary students, which was carried out by Charlotte French MRCVS (pictured right) in 2020, also revealed that 74% of respondents had engaged in extracurricular CPD whilst at university, including university presentations, online conferences, webinars and in-person congresses.
98% said they were willing to be involved in extracurricular CPD if it was available.
Charlotte said: "Students are interested in CPD and their career progression, they just need a little extra help in finding the right providers and sources."
The event is held every four years and hosted alternately by BEVA and the American Association of Equine Practitioners (AAEP).
It offers the opportunity for equine vets to absorb and digest the latest knowledge, clinical practice and scientific advances in the treatment and prevention of colic, from the world’s leading international equine gastroenterology experts.
Held over 2.5 days, the symposium comprises numerous 12-minute oral presentations on a range of topics including surgical techniques, treatment, parasitology, gastric ulceration, endotoxemia, pharmacology of intestinal motility, colic complications, epidemiology, physiology of digestion, the intestinal microbiome and metabolomics.
Each session will be followed by three minutes for questions and discussion.
Poster sessions on the first two days will cover ground beyond the oral presentations and delegates will be able to review and discuss the work with presenters.
There will also be opportunities to network with other equine vets, researchers and professionals.
Clinicians and scientists have until 1 February 2024 to submit abstracts of recent work that they wish to present at this meeting.
The scientific committee will consider abstracts on all aspects of equine gastroenterology, including basic science research and reports of clinical cases or novel approaches to treatment.
The abstract submission form is here: https://form.jotform.com/230473925626359
Tickets cost £475 (with a concessionary rate of £235 for post graduate students and interns) and includes a drinks reception on both 10th & 11th, an evening buffet and Ceilidh on 11th and lunch on 11th & 12th.
Further information and booking details can be found here: https://www.beva.org.uk/Education/CPD/Event-Details/eventDateId/1740
Over half way through Intervet's National Vaccination Month, and according to the company, over 2100 practices are taking part.
Various statistics the company has released, which you might find interesting:
Nearly two thirds of all vet practices have seen parvovirus, in the past year, while 43% have seen leptospirosis, which is spread by rats.
62% of pet owners consider their animal to be an extremely important member of the family with over half (58%) buying them Christmas presents and over one in four (27%) taking time off work for their pet.
However, only 56% of these pets were vaccinated and around more than quarter (28%) of owners were unaware of any disease risk.
Currently, 3 million dogs, 6 million cats and 1.8 million rabbits are unvaccinated, leaving them at risk of a range of fatal diseases, many of which are untreatable.
Intervet has put together an impressive range of support materials for National Vaccination Month, including a pet-owner website: http://www.vaccinationmonth.co.uk/, a discount voucher scheme (on the website) for use in participating practices, TV advertising and a Vaccination Month Podcast primarily aimed at owners.
An international group of scientists has published new results that herald a breakthrough in finding a vaccine against the most commonly diagnosed infectious disease of horses, strangles.
UK experts from the Animal Health Trust collaborated with scientists from the Swedish University of Agricultural Sciences (SLU), the Karonlinska Institutet Medical University and Intervacc AB, on the project - the results of which could benefit humans as well as animals.
Professor Andrew Waller, Head of Bacteriology at the AHT, said: "We have been working towards developing a vaccine for 7 years, and finally it seems as if all the hard work is paying off. We've already developed better ways of diagnosing exposure to the infection, and now, with the success of creating a safe and effective vaccine, it looks as if we're finally bringing together the tools necessary to eradicate this terrible disease."
The vaccine consists of seven different Streptococcus proteins and results from early tests published in PLoS Pathogens have been incredibly positive showing a high level of protection and no side effects. It is hoped that the strangles vaccine could be commercially available in the near future.
Streptococcus equi, the bacterium that causes strangles, shares 80 per cent identity with Streptococcus pyogenes - the leading cause of bacterial pharyngitis, tonsillitis and rheumatic fever in humans, which kills thousands of people each year. Scientists hope that the knowledge gained through developing the strangles vaccine will also help in developing vaccines to combat these human conditions.
Research leader, Professor Bengt Guss of SLU, said: "This is a most exciting project, where research is generating new applications and knowledge that can be used to develop vaccines against these important bacteria. This is particularly important considering the increased number of infectious diseases caused by antibiotic-resistant bacteria."
The vaccine development work was only made possible thanks to information from the Streptococcus equi genome sequencing project funded by The Horse Trust.
The Horse Trust's Chief Executive Brigadier Paul Jepson, said: "We are absolutely delighted that by pulling apart the genome of this plague of the horse world scientists have generated a truly safe and effective strangles vaccine. That this work could also benefit other animal and human health is beyond our wildest hopes."
Full text of the research findings can be found in PLoS Pathogens online at http://www.plospathogens.org/article/info%3Adoi%2F10.1371%2Fjournal.ppat.1000584
The company points to an increasing trend across Europe towards feeding raw diets to pets, with 4% of UK cats and 10% of UK dogs now being fed raw meat and animal by-products.
The webinar, which will also look at the role of testing, offers an opportunity to learn more about the pathogens and parasites associated with raw feeding and the role of the right test at the right time.
Horiba says it's not just pets that need testing, but the raw materials used in their food.
Ian, who is Head of ESCCAP (the European Scientific Council for Companion Animal Parasites) UK & Ireland, said: “The recent trend of increasing raw feeding opens up new opportunities for pathogen transmission.
"Where raw feeding is taking place, adequate tapeworm and protozoal parasite prevention is essential to reduce zoonotic risk and economic losses.
“Testing forms an essential part of their control, and understanding this role and the diagnostic test options available will prove valuable to all veterinary professionals.”
Following Ian's presentation, there will be an open Q&A session.
Horiba’s team of veterinary specialists will also be available at the end of the webinar to discuss and advise on any testing needs, including its veterinary PCR system, the POCKIT Central.
To register, visit: https://register.gotowebinar.com/register/4306408134214190348
Guernsey-based vet, VetSurgeon member David Chamberlain has officially launched a revolutionary cat flap which synchronises with a cat's microchip to control access to the house. The Pet Porte Microchip Cat Flap is the first cat flap that works in conjunction with microchips and has already been winning awards.
Aside from allowing only the homeowner's cats into the house, the Pet Porte Microchip Cat Flap has a number of other interesting features. ‘Vet Mode' allows recognised cats in, but does NOT allow them out, useful when a trip to the vet is on the calendar. ‘Night Mode' uses an automatic daylight sensor to lock the door as ambient light levels drop, keeping cats inside and safe. An audible beep (which can be turned off) provides an alert when a programmed cat enters though the flap.
The Pet Porte Microchip Cat Flap recognises 15 digit UK/European FDX-B microchips. Owners of cats that have already beed chipped can check check compatibility with the Pet Porte's 'Chip Checker'.
The cat flap can recognise up to 32 microchipped cats, and programming it is very simple. When the unit is first installed, the owner holds down a green paw button for ten seconds and passes their cat under the porch for the microchip to be programmed into the system.
A review on Pet Porte's website caught my eye:"Just like to say how absolutely fabulous the cat flap is. I've slashed my cat food bill now I'm not feeding the entire street!" On top of that, as Pet Porte says, this system also encourages microchipping, an important part of responsible pet ownership.
The Pet Porte microchip cat flap is currently being marketed in the UK through veterinary practices and online from http://www.petporte.com/. For all sales enquiries call 01481 265 359, email sales@petporte.com or visit www.petporte.com.
Alternatively, 'Start a Conversation' directly with David by clicking the link on his VetSurgeon profile.
Woodley Equipment Company Ltd has announced the launch of InSight rapid diagnostic test kits. The test range includes FeLV, FIV, FeLV-FIV Combi, Giardia, Canine Heartworm, Canine Parvovirus and with more tests in development.
The test kits are available to veterinary practices across the UK and to Woodley's global veterinary diagnostic distributors. Each test is based on a sandwich lateral flow immunochromatographic assay and contains 10 cassettes per box. The company says that the diagnostic kits are simple and easy to use and will provide point of care testing direct to the veterinary practice. The kits are stored at room temperature (2⁰C - 30⁰C).
The range of InSight Rapid Diagnostic Tests includes:
To place an order, email sales@woodleyequipment.com, fax 01204 669034, or telephone 01204 669033.
For more information, visit: http://www.woodleyequipment.com/.
Petplan is running its television advertising campaign from now until October.
The advert (below) is airing on Sky 1, Sky Atlantic, ITV2, ITV3, More 4, Gold and USA.
Suzanne Cheadle, Acting Head of Marketing at Petplan said: "As the UK market leader, it is imperative that pet owners recognise and understand who we are and what we stand for. We need to help pet owners understand not only why pet insurance is so important, but explain why they should choose Petplan over any other provider. In 36 years, there's not an illness or accident that we haven't seen, and our Covered For Life policies have been developed with unrivalled knowledge and experience."
Wiley has announced the joint online publication of a special issue of 22 ophthalmology papers from Equine Veterinary Journal, Equine Veterinary Education and Veterinary Ophthalmology.
Clinical equine ophthalmology: The current state of the art brings together papers on some of the most significant advances in equine clinical ophthalmology into a single issue to make them more readily available to a wider audience. The issue contains information of direct relevance to all sectors of the veterinary profession from general practitioners and specialists to researchers, surgeons and students, covering common diseases, surgical procedures and outcomes.
The new publication was devised and compiled by a panel of guest editors comprising Mary Lassaline, member of the Veterinary Ophthalmology Editorial board and Veterinary Ophthalmologist in the Department of Surgical and Radiological Sciences at UC-Davis School of Veterinary Medicine, California, David A. Wilkie, Editor of Veterinary Ophthalmology and Professor at Veterinary Clinical Sciences Comparative Ophthalmology Ohio State University, Tim Mair, Editor of Equine Veterinary Education based at Bell Equine Veterinary Clinic, Kent and Celia M Marr, Editor of Equine Veterinary Journal, based at Rossdales, Newmarket.Mary Lassaline said: "The goal was to provide broad access to the most current information applicable to every stratum of the equine veterinary profession. Subsequently, a salient feature is that many of the papers included are collaborations between veterinary ophthalmologists with a special interest in horses, equine practitioners with a special interest in ophthalmology, private practitioners and those in academia, and academicians from different institutions."
Subjects covered include seven papers on new approaches to the diagnosis and treatment of ulcerative and non-ulcerative keratitis in the horse. There are three articles on novel approaches to corneal surgery and a further three on corneal neoplasia. Six papers provide valuable data regarding long-term outcomes following surgical intervention for Equine Recurrent Uveitis (ERU), glaucoma, and cataracts. Finally, three articles present new information regarding retinal and orbital disease.
Professor Celia Marr, Editor of the Equine Veterinary Journal said: "The key purpose of the EVJ is to disseminate information to help the enhancement of specialist knowledge at every level of the veterinary profession. By collating the most important and up-to-date ophthalmology research into one easy resource the new special issue does exactly that."The ophthalmology special issue is available free online at: http://bit.ly/1bi0RG0